1st Quarter - Report

CROWELL GLOBAL ADVISORS for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Free Trade Agreements (Korea, TPP), Generalized System of Trade Preferences, National Trade Estimate

LobbyistCovered position, as disclosed
KATE CLEMANS —
PAUL JOHN DAVIES New —
CONOR B HARRINGTON New —
AMY JEAN JACKSON —

Contacted: Natl Institutes of Health (NIH); Commerce, Dept of (DOC); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); State, Dept of (DOS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.